Dr Jayanta Datta is a senior nephrology specialist at Manipal Hospitals Salt Lake, Kolkata, with a strong educational background (MBBS, MD, DM) and extensive experience in kidney transplantation, dialysis therapies and management of complex renal conditions. He is affiliated with multiple leading nephrology societies and is committed to patient-centric care in advanced kidney disease. 

Educational Qualifications:

• MBBS
  
• MD
  
• DM (Nephrology) – IPGMER / SSKM
  
  

Professional Experience:

• Senior Consultant – Nephrology, Manipal Hospitals Salt Lake, Kolkata 
• Investigator / author of nephrology research studies including “Mycophenolate Mofetil-An Angel in FSGS”, “Use of everolimus in ADPKD”, CAPD catheter loss study, comparative study of cyclosporine & tacrolimus in post-transplant patients.
  
  

Awards & Achievements:

• MBBS- Gold medal & Distinction in Medicine and Gynaecology & Obstetrics
• MD-Highest score in the University College of Medicine
• DM – Highest mark in that year at the university

‍

Professional Memberships:‍

• Indian Society of Nephrology
• Indian Academy of Nephrology
• American Society of Nephrology
• European Renal Association and EDTA
• International Society of Nephrology

Publications:

• Wrote a chapter on quality of water in the Haemodialysis unit in “Handbook of haemodialysis” published by the Indian Academy of Nephrology.
• Paper “spectrum of acute kidney injury in obstetric patients” in the Journal of Indian Medical Association.
• “Spectrum of renal dysfunction in dengue fever “ in JIMA.
• Principal Investigator “Role of CERA” in Haemodialysis patients.
• Mycophenolate Mofetil- An Angel In FSGS in ISN (Indian Society Of Nephrology)
• Causes of catheter loss in CAPD patients of ESI Hospital, Manicktala, in the annual conference of the International Society of Peritoneal Dialysis, Seoul rewarded with a travel grant for attending.
• Presented a comparative study on cyclosporine & tacrolimus in post-transplant patients in the Indian Society of Nephrology.
• Poster presentation on pre-emptive use of everolimus in renal transplantation at the International Society of Nephrology.
• PI & co-investigation of ongoing studies:
• Use of everolimus in ADPKD (adult polycystic kidney disease)
• Comparative study of APD & CAPD patients
• Spectrum of renal involvement in patients who are admitted to the ICU.
• Published manuals of standard operating procedure for haemodialysis & peritoneal dialysis for the dialysis network, ESI (MB) scheme, West Bengal
  

Video Presentations:

“World Kidney Day 2022, Dr Jayanta Datta, Consultant Nephrologist, Manipal Hospital Salt Lake” – video on hospital site